Schedule 13G ownership disclosure
MERSANA THERAPEUTICS INC
Security class unavailable · CUSIP: 59045L106
Event date: 2021-01-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,770,000
- Percent of class
- 5.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-21-000081
- Form type
- SC 13G
- Filer
- Mersana Therapeutics, Inc.
- CIK
- CIK 1442836
- Filed
- Jan 25, 2021
- Reporting period
- Jan 15, 2021
- Description
- Schedule 13G beneficial ownership